| 1 |
enhancer of zeste homolog 2
(1492 times)
|
Neoplasms
(447 times)
|
PRC2 (174 times)
lncRNAs (78 times)
HCC (63 times)
|
2002 The polycomb group protein EZH2 is involved in progression of prostate cancer.
|
| 2 |
enhancer of zeste 2
(80 times)
|
Neoplasms
(17 times)
|
PRC2 (22 times)
EED (7 times)
SUZ12 (6 times)
|
2003 Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development.
|
| 3 |
enhancer of zeste 2 polycomb repressive complex 2 subunit
(51 times)
|
Neoplasms
(17 times)
|
lncRNAs (11 times)
ChIP (5 times)
EMT (4 times)
|
2015 Activation of SAPK/JNK mediated the inhibition and reciprocal interaction of DNA methyltransferase 1 and EZH2 by ursolic acid in human lung cancer cells.
|
| 4 |
Enhancer of Zeste, Drosophila, Homologue 2
(6 times)
|
Neoplasms
(1 time)
|
ET (3 times)
DC (1 time)
DPYD (1 time)
|
2009 EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation.
|
| 5 |
expression of zester homolog 2
(4 times)
|
Neoplasms
(1 time)
|
AML (1 time)
ARR (1 time)
BCa (1 time)
|
2017 HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
|
| 6 |
expression of miR-101 and zeste homolog 2
(3 times)
|
Medicine
(1 time)
|
AAA (1 time)
Ang II (1 time)
ATL-1 (1 time)
|
2014 miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer.
|
| 7 |
recruits zeste homolog 2
(2 times)
|
Nucleic Acids
(1 time)
|
BRCA1 (1 time)
FAD (1 time)
GAPDH (1 time)
|
2019 lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2.
|
| 8 |
component-enhancer of zeste homolog 2
(1 time)
|
Pigmentation
(1 time)
|
PRC2 (1 time)
|
2016 EZH2 as a mediator of treatment resistance in melanoma.
|
| 9 |
effect of zeste homolog 2
(1 time)
|
Neoplasms
(1 time)
|
WF (1 time)
|
2017 Effect of wound fluid on chemotherapy sensitivity of T24 bladder cancer cells with different enhancer of zeste homolog 2 status.
|
| 10 |
enhancer of zeste 2 polycomb
(1 time)
|
Biochemistry
(1 time)
|
ESCs (1 time)
ME (1 time)
|
2018 Activin/Smad2 and Wnt/beta-catenin up-regulate HAS2 and ALDH3A2 to facilitate mesendoderm differentiation of human embryonic stem cells.
|
| 11 |
enhancer of zeste 2 PRC2 subunit
(1 time)
|
Molecular Biology
(1 time)
|
GDF15 (1 time)
PRC2 (1 time)
TEAD (1 time)
|
2018 YAP promotes breast cancer metastasis by repressing growth differentiation factor-15.
|
| 12 |
enhancer of zeste2 gene
(1 time)
|
Biochemistry
(1 time)
|
---
|
2014 Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the beta-catenin gene.
|
| 13 |
Enhancer Zeste of Homolog 2
(1 time)
|
Cell Biology
(1 time)
|
ARMS (1 time)
PKC (1 time)
RMS (1 time)
|
2017 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells.
|
| 14 |
ERalpha physically interacts with the zeste homolog 2
(1 time)
|
|
ERalpha (1 time)
MSCs (1 time)
|
2021 Estrogen receptor alpha regulates the expression of adipogenic genes genetically and epigenetically in rat bone marrow-derived mesenchymal stem cells.
|
| 15 |
expression levels of PRMT1, Zeste Homolog 2
(1 time)
|
Rheumatology
(1 time)
|
FLS (1 time)
MMP-2 (1 time)
PRMT1 (1 time)
|
2022 Protein arginine methyltransferase 1 upregulates matrix metalloproteinase-2/9 expression via Zeste Homolog 2 to promote human rheumatoid arthritis fibroblast-like synovial cell survival and metastasis.
|
| 16 |
expression of ANKRD1 and ANGPTL4 by recruiting zeste homolog 2
(1 time)
|
Cell Biology
(1 time)
|
lncRNAs (1 time)
PC (1 time)
|
2019 RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
|
| 17 |
expression patterns of LINC00152, Zeste Homologue 2
(1 time)
|
Cell Transformation, Neoplastic
(1 time)
|
EC (1 time)
EMT (1 time)
|
2020 LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2.
|
| 18 |
EZH2 histone methyltransferase
(1 time)
|
Medicine
(1 time)
|
---
|
2016 An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
|
| 19 |
EZH2Delta550-738 lacking SET domain
(1 time)
|
Neoplasms
(1 time)
|
MCL (1 time)
PRC2 (1 time)
|
2020 Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b.
|
| 20 |
EZH2TAD
(1 time)
|
Biochemistry
(1 time)
|
AR (1 time)
AR-V7 (1 time)
CRPC (1 time)
|
2022 A cryptic transactivation domain of EZH2 binds AR and AR's splice variant, promoting oncogene activation and tumorous transformation.
|
| 21 |
increased Zeste homolog 2
(1 time)
|
Neoplasms
(1 time)
|
VASH1 (1 time)
|
2010 Regulation of tumor angiogenesis by EZH2.
|
| 22 |
methyltransferase zeste homolog 2
(1 time)
|
Neoplasms
(1 time)
|
DZNep (1 time)
|
2015 Ribavirin as a tri-targeted antitumor repositioned drug.
|
| 23 |
Notch-c-Myc-enhancer of zeste homolog 2
(1 time)
|
Immunotherapy
(1 time)
|
CLL (1 time)
PD-L1 (1 time)
|
2021 Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis.
|
| 24 |
recruiting Zeste homologous protein 2 enhancer
(1 time)
|
Stem Cells
(1 time)
|
IM (1 time)
|
2022 lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia.
|
A Search Service for Abbreviation / Long Form